203
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

The searching for agents for Alzheimer’s disease treatment via the system of self-consistent models

ORCID Icon, ORCID Icon, ORCID Icon, &
Pages 549-557 | Received 11 Jan 2022, Accepted 11 Mar 2022, Published online: 07 Apr 2022

References

  • Ahmadi S. 2020. Mathematical modeling of cytotoxicity of metal oxide nanoparticles using the index of ideality correlation criteria. Chemosphere. 242:125192.
  • Ahmadi S, Akbari A. 2018. Prediction of the adsorption coefficients of some aromatic compounds on multi-wall carbon nanotubes by the Monte Carlo method. SAR QSAR Environ Res. 29(11):895–909.
  • Bagri K, Kumar A, Nimbhal M, Kumar P. 2020. Index of ideality of correlation and correlation contradiction index: a confluent perusal on acetylcholinesterase inhibitors. Mol Simul. 46(10):777–786.
  • Berhanu WM, Pillai GG, Oliferenko AA, Katritzky AR. 2012. Quantitative structure-activity/property relationships: The ubiquitous links between cause and effect. ChemPlusChem. 77(7):507–517.
  • Bhargava S, Adhikari N, Amin SA, Das K, Gayen S, Jha T. 2017. Hydroxyethylamine derivatives as HIV-1 protease inhibitors: a predictive QSAR modelling study based on Monte Carlo optimization. SAR QSAR Environ Res. 28(12):973–990.
  • Blasko I, Beer R, Bigl M, Apelt J, Franz G, Rudzki D, Ransmayr G, Kampfl A, Schliebs R. 2004. Experimental traumatic brain injury in rats stimulates the expression, production and activity of Alzheimer's disease β-secretase (BACE-1). J Neural Transm. 111(4):523–536.
  • Cao D-S, Xu Q-S, Liang Y-Z, Chen X, Li H-D. 2010. Prediction of aqueous solubility of druglike organic compounds using partial least squares, back-propagation network and support vector machine. J Chemom. 24 (9):584–595.
  • Choubey PK, Tripathi A, Tripathi MK, Seth A, Shrivastava SK. 2021. Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease. Bioorg Chem. 111:104922
  • Cruz DS, Castilho MS. 2014. 2D QSAR studies on series of human beta-secretase (BACE-1) inhibitors. Med Chem. 10(2):162–173.
  • Dhanjal JK, Goyal S, Sharma S, Hamid R, Grover A. 2014. Mechanistic insights into mode of action of potent natural antagonists of BACE-1 for checking Alzheimer's plaque pathology. Biochem Biophys Res Commun. 443(3):1054–1059.
  • Ghasemi J, Saaidpour S, Brown SD. 2007. QSPR study for estimation of acidity constants of some aromatic acids derivatives using multiple linear regression (MLR) analysis. J Mol Struct THEOCHEM. 805(1-3):27–32.
  • Ghiasi T, Ahmadi S, Ahmadi E, Talei Bavil Olyai MR, Khodadadi Z. 2021. The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors. SAR QSAR Environ Res. 32(6):495–520.
  • Hunt CE, Turner AJ. 2009. Cell biology, regulation and inhibition of beta-secretase (BACE-1) ). Febs J. 276(7):1845–1859.
  • Jafari K, Fatemi MH, Toropova AP, Toropov AA. 2022. The development of nano-QSPR models for viscosity of nanofluids using the index of ideality of correlation and the correlation intensity index. Chemometr Intell Lab Syst. 222:104500.
  • Javidfar M, Ahmadi S. 2020. QSAR modelling of larvicidal phytocompounds against Aedes aegypti using index of ideality of correlation. SAR QSAR Environ Res. 31(10):717–739.
  • Kumar A, Bagri K, Nimbhal M, Kumar P. 2021. In silico exploration of the fingerprints triggering modulation of glutaminyl cyclase inhibition for the treatment of Alzheimer's disease using SMILES based attributes in Monte Carlo optimization. J Biomol Struct Dyn. 39(18):7181–7193.
  • Kumar P, Kumar A. 2021. Correlation intensity index (CII) as a benchmark of predictive potential: Construction of quantitative structure activity relationship models for anti-influenza single-stranded DNA aptamers using Monte Carlo optimization. J Mol Struct. 1246:131205.
  • Kumar P, Kumar A, Sindhu J. 2019. Design and development of novel focal adhesion kinase (FAK) inhibitors using Monte Carlo method with index of ideality of correlation to validate QSAR. SAR QSAR Environ Res. 30 (2):63–80.
  • Neumann U, Ufer M, Jacobson LH, Rouzade-Dominguez M-L, Huledal G, Kolly C, Lüönd RM, Machauer R, Veenstra SJ, Hurth K, et al. 2018. The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease. EMBO Mol Med. 10(11):e9316.
  • Ničković VP, Mitić NR, Krdžić BD, Krdžić JD, Nikolić GR, Vasić MZ, Ranković G, Babović P, Sokolović D, Veselinović AM. 2020. Design and development of novel therapeutics for brucellosis treatment based on carbonic anhydrase inhibition. J Biomol Struct Dyn. 38(6):1848–1857.
  • Nimbhal M, Bagri K, Kumar P, Kumar A. 2020. The index of ideality of correlation: A statistical yardstick for better QSAR modeling of glucokinase activators. Struct Chem. 31(2):831–839.
  • Panek D, Więckowska A, Pasieka A, Godyń J, Jończyk J, Bajda M, Knez D, Gobec S, Malawska B. 2018. Design, synthesis, and biological evaluation of 2-(benzylamino-2-hydroxyalkyl)isoindoline-1,3-diones derivatives as potential disease-modifying multifunctional anti-Alzheimer agents. Molecules. 23(2):347.
  • Prati F, Bottegoni G, Bolognesi ML, Cavalli A. 2018. BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer's Disease. J Med Chem. 61(3):619–637.
  • Ribaudo G, Coghi P, Zanforlin E, Law BYK, Wu YYJ, Han Y, Qiu AC, Qu YQ, Zagotto G, Wong VKW. 2019. Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer's disease. Bioorg Chem. 87:474–483.
  • Stoyanova-Slavova IB, Slavov SH, Pearce B, Buzatu DA, Beger RD, Wilkes JG. 2014. Partial least square and k-nearest neighbor algorithms for improved 3D quantitative spectral data-activity relationship consensus modeling of acute toxicity. Environ Toxicol Chem. 33(6):1271–1282.
  • Subramanian G, Poda G. 2018. In silico ligand-based modeling of hBACE-1 inhibitors. Chem Biol Drug Des. 91(3):817–827.
  • Toropov AA, Sizochenko N, Toropova AP, Leszczynska D, Leszczynski J. 2020. Advancement of predictive modeling of zeta potentials (ζ) in metal oxide nanoparticles with correlation intensity index (CII). J Mol Liq. 317:113929.
  • Toropov AA, Toropova AP. 2019. Use of the index of ideality of correlation to improve predictive potential for biochemical endpoints. Toxicol Mech Methods. 29(1):43–52.
  • Toropov AA, Toropova AP. 2020. Correlation intensity index: Building up models for mutagenicity of silver nanoparticles. Sci Total Environ. 737:139720
  • Toropov AA, Toropova AP. 2021. The system of self-consistent models for the uptake of nanoparticles in PaCa2 cancer cells. Nanotoxicology. 15(7):995–1004.
  • Toropov AA, Toropova AP, Benfenati E. 2020. 'Ideal correlations' for the predictive toxicity to Tetrahymena pyriformis. Toxicol Mech Methods. 30(8):605–610.
  • Toropov AA, Toropova AP, Benfenati E, Salmona M. 2018. Mutagenicity, anticancer activity and blood brain barrier: similarity and dissimilarity of molecular alerts. Toxicol Mech Methods. 28(5):321–327.
  • Toropova AP, Toropov AA. 2014. CORAL software: Prediction of carcinogenicity of drugs by means of the Monte Carlo method. Eur J Pharm Sci. 52(1):21–25.
  • Toropova AP, Toropov AA. 2019. Does the Index of Ideality of Correlation Detect the Better Model Correctly? Mol Inf. 38(8-9):1800157.
  • Toropova AP, Toropov AA. 2020. Fullerenes C60 and C70: a model for solubility by applying the correlation intensity index. Fuller Nanotub Carbon Nanostructures. 28(11):900–906.
  • Toropova AP, Toropov AA. 2021. The System of Self-Consistent of Models: A New Approach to Build Up and Validation of Predictive Models of the Octanol/Water Partition Coefficient for Gold Nanoparticles. Int J Environ Res. 15(4):709–722.
  • Toropova AP, Toropov AA. 2022. Nanomaterials: quasi-SMILES as a flexible basis for regulation and environmental risk assessment. Sci Total Environ. 823:153747.
  • Toropova AP, Toropov AA, Begum S, Achary PGR. 2018. Blood brain barrier and Alzheimer's Disease: Similarity and Dissimilarity of Molecular Alerts. Curr Neuropharmacol. 16(6):769–785.
  • Toropova MA, Toropov AA, Raška I, Rašková M. 2015. Searching therapeutic agents for treatment of Alzheimer disease using the Monte Carlo method. Comput Biol Med. 64:148–154.
  • Tripathi A, Choubey PK, Sharma P, Seth A, Tripathi PN, Tripathi MK, Prajapati SK, Krishnamurthy S, Shrivastava SK. 2019. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease. Eur J Med Chem. 183:111707
  • Zhang L, Shen C, Chu J, Zhang R, Li Y, Li L. 2014. Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer's disease. Int J Biol Sci. 10(2):181–191.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.